BioSpace

DNA Microarray Market Size to Grow approximately USD 6.13 Bn by 2034

As per precedence Research, the global DNA microarray market size is projected to grow approximately USD 6.13 billion by 2034 from valued at USD 2.28 billion in 2023. It is expanding at a CAGR of 9.4% ...
Frontiers

Deep characterization of human γδ T cell subsets defines shared and lineage-specific traits

Under non-pathological conditions, human γδ T cells represent a small fraction of CD3 + T cells in peripheral blood (1-10%). They constitute a unique subset of T lymphocytes that recognize stress ...
BioSpace

Agilent Receives Approval for GenetiSure Dx Postnatal Assay in Japan

SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies Inc. (NYSE: A) announced it has obtained clearance from the Ministry of Health, Labour and Welfare (MHLW) in Japan for the GenetiSure Dx ...
360dx

Agilent Receives Approval for Microarray-Based Postnatal Assay in Japan

NEW YORK ─ Agilent Technologies on Tuesday announced it has obtained clearance from Japan's Ministry of Health, Labour, and Welfare for its GenetiSure Dx Postnatal Assay, bringing comparative genomic ...
Frontiers

Effects of Low-Level Er:YAG Laser Irradiation on Proliferation and Calcification of Primary Osteoblast-Like Cells Isolated From Rat Calvaria

Photo-bio-modulation of low-level laser therapy (LLLT) has beneficial effects on multiple cell types (Huang et al., 2009; AlGhamdi et al., 2012); consequently, it has been used in medical and dental ...
Nasdaq

Agilent Introduces Three New Microarrays for Prenatal and Postnatal Research

SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies Inc. (NYSE: A) today introduced three new microarrays to meet the needs of cytogenetic laboratories conducting both prenatal and postnatal ...